• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON UNSPECIFIED BD INFUSION SET; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON UNSPECIFIED BD INFUSION SET; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number UNKNOWN
Device Problem Excess Flow or Over-Infusion (1311)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/13/2022
Event Type  malfunction  
Manufacturer Narrative
Date of event: unknown.The date received by manufacturer has been used for this field.Device evaluation: a device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.Device expiration date: unknown.Device manufacture date: unknown.Unknown manufacturer: there are multiple bd locations where this unspecified bd device may have been manufactured.A catalog and lot number could not be confirmed for this incident and without this information we are unable to determine where the device was manufactured.Therefore, bd corporate headquarters in (b)(6) has been listed in sections d.3.And g.1.And the (b)(6) fda registration number has been used for the manufacture report number.
 
Event Description
It was reported that the unspecified bd infusion set experienced over-infusion with the secondary medication.The following information was provided by the initial reporter: it was a reported over-infusion with a secondary medication.Clinical staff were able to confirm based on the colour of the primary fluid that back-flow of secondary into the primary did not occur.
 
Manufacturer Narrative
The following fields were updated due possible lots: d4: medical device lot #: 22075907.D4: medical device expiration date: 02aug2025.H4: device manufacture date: 02aug2022.D4: medical device lot #: 22076014.D4: medical device expiration date: 03aug2025.H4: device manufacture date: 03aug2022.D4: medical device lot #: 22085032.D4: medical device expiration date: 03aug2025.H4: device manufacture date: 03aug2022.D4: medical device lot #: 22085073.D4: medical device expiration date: 10aug2025.H4: device manufacture date: 10aug2022.D4: medical device lot #: 22085074.D4: medical device expiration date: 11aug2025.H4: device manufacture date: 11aug2022.D4: medical device lot #: 22085416.D4: medical device expiration date: 10aug2025.H4: device manufacture date: 10aug2022.D4: medical device lot #: 22085436.D4: medical device expiration date: 11aug2025.H4: device manufacture date: 11aug2022.D4: medical device lot #: 22085438.D4: medical device expiration date: 10aug2025.H4: device manufacture date: 10aug2022 the following fields were updated due to additional information: d10: device available for eval yes.D10: returned to manufacturer on: h6: investigation summary it was observed during functional testing on returned set model 2420-0007 lot unknown that a backflow was observed.A quality notification was sent to the supplier, and the failed back check valve was sent for further investigation.For the supplier investigation, particulate presence could not be confirmed.The check valve was inspected for backflow on bench testers and backflow failure was not observed.Given the findings, the supplier is unable to confirm the reported failure mode of backflow and will close with no further actions.The root cause was unable to be determined.A lot is unknown, however, possible lots were identified to be: 22075907, 22076014, 22085032, 22085073, 22085074, 22085416, 22085436, 22085438.A device history record review for model 2420-0007 lot number 22075907 was performed.There was a quality notification issued for the failure mode reported by the customer during the production build of this set for the lot 22075907 as notification id #200335547 on 04aug2022.A device history record review for model 2420-0007 lot number 22076014 was performed.There were no quality notifications issued for the failure mode reported by the customer during the production build of this set.A device history record review for model 2420-0007 lot number 22085032 was performed.There were no quality notifications issued for the failure mode reported by the customer during the production build of this set.A device history record review for model 2420-0007 lot number 22085073 was performed.There were no quality notifications issued for the failure mode reported by the customer during the production build of this set.A device history record review for model 2420-0007 lot number 22085074 was performed.There were no quality notifications issued for the failure mode reported by the customer during the production build of this set.A device history record review for model 2420-0007 lot number 22085416 was performed.There were no quality notifications issued for the failure mode reported by the customer during the production build of this set.A device history record review for model 2420-0007 lot number 22085436 was performed.There were no quality notifications issued for the failure mode reported by the customer during the production build of this set.A device history record review for model 2420-0007 lot number 22085438 was performed.There were no quality notifications issued for the failure mode reported by the customer during the production build of this set.H3 other text : see h10.
 
Event Description
It was reported that the unspecified bd infusion set experienced over-infusion with the secondary medication.The following information was provided by the initial reporter: it was a reported over-infusion with a secondary medication.Clinical staff were able to confirm based on the colour of the primary fluid that back-flow of secondary into the primary did not occur.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNSPECIFIED BD INFUSION SET
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BECTON DICKINSON
1 becton drive
franklin lakes NJ 07417
Manufacturer (Section G)
BECTON DICKINSON
1 becton drive
franklin lakes NJ 07417
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key16081860
MDR Text Key308569189
Report Number2243072-2022-02261
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
UNKNOWN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue NumberUNKNOWN
Device Lot NumberSEE H10
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/13/2022
Initial Date FDA Received01/02/2023
Supplement Dates Manufacturer Received04/17/2023
Supplement Dates FDA Received04/25/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-